William J. McLean Ph.D. Net Worth

Mr. William J. McLean Ph.D. biography

William J. McLean Ph.D. is the Co-founder & Sr. VP of Hearing Biology and Translational Research at Frequency Therapeutics Inc.

What's Mr D's mailing address?

William's mailing address filed with the SEC is C/O FREQUENCY THERAPEUTICS, INC.,, 19 PRESIDENTIAL WAY, 2ND FLOOR, WOBURN, MA, 01801.

Insiders trading at Frequency Therapeutics Inc

Over the last 5 years, insiders at Frequency Therapeutics Inc have traded over 11,017,122$ worth of Frequency Therapeutics Inc stock and bought 369,233 units worth 5,339,982$ . The most active insiders traders include Joel S Marcus、Robert Langer、Marc A Cohen. On average, Frequency Therapeutics Inc executives and independent directors trade stock every 11 days with the average trade being worth of 3,858$. The most recent stock trade was executed by Richard J. Mitrano on 18 August 2023, trading 464 units of FREQ stock currently worth 269$.

What does Frequency Therapeutics Inc do?

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.

Frequency Therapeutics Inc executives and stock owners

Frequency Therapeutics Inc executives and other stock owners filed with the SEC include:

• David Lucchino,
  President, Chief Executive Officer, Co-Founder, Director
• Christopher Loose,
  Co-Founder, Chief Scientific Officer
• Carl LeBel,
  Chief Development Officer
• David L. Lucchino,
  Co-Founder, Pres, CEO & Director
• Wendy S. Arnold,
  Chief People Officer
• Peter P. Pfreundschuh,
  Chief Financial Officer
• Robert Langer,
  Independent Director
• Marc Cohen,
  Lead Independent Chairman of the Board Director
• Joel Marcus,
  Independent Director
• Michael Huang,
  Independent Director
• Timothy Barberich,
  Independent Director
• Carlo Tanzi,
  IR Contact Officer
• Cynthia Feldmann,
  Independent Director
• Dana Hilt,
  Chief Medical Officer
• Ajay Rai,
  Vice President - Business Development
• Richard Mitrano,
  Vice President of Finance and Operations
• Wendy Arnold,
  Chief People Officer
• William Mclean,
  Co-Founder, Vice President - Biology and Regenerative Medicine
• Dr. Carl P. LeBel,
  Chief Devel. Officer
• Dr. Christopher R. Loose,
  Co­-Founder & Chief Scientific Officer
• Dr. William W. Chin M.D.,
  Sr. VP of Translational Medicine
• Dr. Dana C. Hilt,
  Chief Medical Officer
• Dr. Jeff Hrkach,
  Sr. VP of Technology Devel.
• Richard J. Mitrano,
  VP of Fin. & Operations
• William J. McLean Ph.D.,
  Co-founder & Sr. VP of Hearing Biology and Translational Research
• Quentin Mc Cubbin,
  Chief Manufacturing Officer
• James E Deerfield Mgmt L.P....,
  
• Peter P. Pfreundschuh,
  Chief Financial Officer
• Michael Bookman,
  General Counsel and Secretary